![Andrew Sandler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Sandler
Director/Board Member at
DERMATA THERAPEUTICS, INC.
Net worth: 12 $ as of 31/05/2026
Profile
Andrew S.
Sandler is an Independent Director at Dermata Therapeutics, Inc. since 2021.
Former roles include Director-Clinical Development at Seagen, Inc. in 2003; Chief Medical Officer at Spectrum Pharmaceuticals, Inc. from 2008 to 2010; Head-Global Medical Affairs Oncology Division at Berlex, Inc. in 2006; Chief Medical Officer & Executive Vice President at Dendreon Corp.; Senior Vice President-Medical Affairs at Medivation LLC (California) from 2016 to 2017; VP & Head-Global Medical Affairs Oncology Division at Bayer HealthCare Pharmaceuticals, Inc. from 2006 to 2008; Chief Medical Officer at Kiadis Pharma NV from 2017 to 2022; Chief Medical Officer at Dendreon Pharmaceuticals, Inc. from 2010 to 2015; and Chief Medical Officer at Alpine Immune Sciences, Inc. from 2022 to 2023.
Education includes undergraduate studies at Rochester Christian University and a doctorate from Icahn School of Medicine at Mount Sinai conferred in 1990.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 9 ( 0% ) | 12 $ | 31/05/2026 |
Andrew Sandler active positions
| Companies | Position | Start |
|---|---|---|
| DERMATA THERAPEUTICS, INC. | Director/Board Member | 01/08/2021 |
Former positions of Andrew Sandler
| Companies | Position | End |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 02/10/2023 |
| KIADIS PHARMA N.V. | Chief Tech/Sci/R&D Officer | 01/06/2022 |
| MEDIVATION INC | Chief Tech/Sci/R&D Officer | 01/06/2017 |
Dendreon Pharmaceuticals, Inc.
 Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Chief Tech/Sci/R&D Officer | 01/04/2015 |
| SPECTRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2010 |
Training of Andrew Sandler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Berlex, Inc.
 Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Dermata Therapeutics, Inc.
 Dermata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which focusing on the treatment of medical and aesthetic skin conditions | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
Dendreon Pharmaceuticals, Inc.
Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Andrew Sandler
